Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates

Novel therapeutic and preventive strategies are needed to contain the HIV-1 epidemic. Broadly neutralizing human antibodies (bNAbs) with exceptional activity against HIV-1 are currently being tested in HIV-1 prevention trials. The selection of anti-HIV-1 bNAbs for clinical development was primarily...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Virol
Main Authors: Lorenzi, Julio C. C., Mendoza, Pilar, Cohen, Yehuda Z., Nogueira, Lilian, Lavine, Christy, Sapiente, Joseph, Wiatr, Marie, Mugo, Nelly R., Mujugira, Andrew, Delany, Sinead, Lingappa, Jairam, Celum, Connie, Seaman, Michael S., Caskey, Marina, Nussenzweig, Michel C.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2021
Teme:
Pathogenesis and Immunity
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092834/
https://ncbi.nlm.nih.gov/pubmed/33298542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01909-20
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki